EliseAI Raises $250M to Scale AI Automation Across Healthcare and Housing

"Healthcare and housing systems face unprecedented challenges, with U.S. healthcare administrative costs exceeding $600B annually while property managers struggle with labor shortages and workforce turnover rates above 40%. These industries represent nearly 40% of household spending yet remain notoriously complex and outdated to navigate. EliseAI addresses these pain points through vertical AI workflows that automate the entire consumer journey in both sectors."

"With their recent $250M Series E funding, EliseAI continues expanding their AI-powered solutions that cut administrative costs by up to 25% and eliminate patient wait times while doubling revenue for four consecutive years. AlleyWatch sat down with EliseAI Cofounder and CEO Minna Song to learn more about the business, its future plans, recent funding round, which brings the company's total funding raised to $391.9M, and much, much, much more..."

"Tell us about the product or service that EliseAI offers. EliseAI builds AI workflows that automate the entire consumer journey in housing and healthcare. In healthcare, the platform manages scheduling, questions, and call center operations, cutting administrative costs (more $600B annually in the US healthcare system). In rental housing, Elise AI automates leasing, maintenance, renewals, and tours and already powers 1 in 8 apartments in the U.S."

Healthcare and rental housing face major operational challenges, including over $600B in U.S. healthcare administrative costs, labor shortages, and workforce turnover above 40%. These sectors account for nearly 40% of household spending and suffer from complex, outdated processes. EliseAI builds vertical AI workflows that automate the entire consumer journey across both industries. The platform handles scheduling, patient inquiries, and call center operations in healthcare, and automates leasing, maintenance, renewals, and tours in rental housing, already powering one in eight U.S. apartments. Recent $250M Series E funding led by Andreessen Horowitz supports expansion, enabling cost reductions up to 25%, elimination of patient wait times, and sustained revenue growth.

Read at Alleywatch